![John Senaldi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in John Senaldi first degree
Entity | Entity type | Industry | |
---|---|---|---|
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Senaldi via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Treasurer | |
Alinea Pharmaceuticals, Inc.
![]() Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alinea Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new therapeutics for the treatment of diabetes and metabolic disorders. The company was founded in August 2005 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nichols College | College/University | Masters Business Admin | |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman | |
Anthos Therapeutics, Inc.
![]() Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Other | Chairman | |
Blackstone Life Sciences Advisors LLC
![]() Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Chairman | |
BLACKSTONE INC. | Investment Managers | Corporate Officer/Principal | |
BioMed Realty LP
![]() BioMed Realty LP Real Estate Investment TrustsFinance BioMed Realty LP owns, acquires, develops, redevelops, leases, manages laboratory and office space. The company was founded on April 30, 2004 and is headquartered in San Diego, CA. | Real Estate Investment Trusts | Director/Board Member | |
Stonehill College, Inc. | College/University | Undergraduate Degree | |
EPIZYME, INC. | Biotechnology | Director of Finance/CFO | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wolfe Laboratories, Inc.
![]() Wolfe Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Wolfe Laboratories, Inc. operates as a contract research organization which provides integrated drug development solutions to the biopharmaceutical industry. It offers small molecule drug development, biologics development, and antibody-drug conjugates development services. The company was founded by Janet Wolfe in 1999 and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Director of Finance/CFO | |
DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Avila Therapeutics, Inc.
![]() Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Mitobridge, Inc.
![]() Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Secretary | |
Semma Therapeutics, Inc.
![]() Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
Potenza Therapeutics, Inc.
![]() Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
MPM Asset Management II LLC | Corporate Officer/Principal | ||
David H. Koch Institute for Integrative Cancer Research
![]() David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Nuvelution Pharma, Inc.
![]() Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Venrock Associates
![]() Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Portfolio Manager-Equities | |
AFFYMAX, INC. | Biotechnology | Director/Board Member | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Founder | |
NS WIND DOWN CO., INC. | Biotechnology | Director/Board Member | |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member | |
Millennium Predictive Medicine, Inc. | Founder | ||
Millennium Biotherapeutics, Inc. | Director/Board Member | ||
Caliper Technologies Corp.
![]() Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a leading provider of microfluidic technology and laboratory automation solutions. The private company is based in Mountain View, CA. The company serves a broad range of markets in the worldwide life science, biotechnology, and pharmaceutical industries. The company was founded by J. Michael Ramsey. | Medical Specialties | Director/Board Member | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Reed Institute | College/University | Director/Board Member | |
MPM BioVentures III GP LP | Corporate Officer/Principal |
Statistics
International
United States | 50 |
United Kingdom | 2 |
Sectoral
Health Technology | 32 |
Finance | 8 |
Consumer Services | 4 |
Commercial Services | 3 |
Electronic Technology | 2 |
Operational
Director/Board Member | 23 |
Director of Finance/CFO | 11 |
Independent Dir/Board Member | 9 |
Corporate Officer/Principal | 8 |
Chairman | 6 |
Most connected contacts
Insiders | |
---|---|
Nicholas G. Galakatos | 38 |
David N. Cordo | 18 |
Robert Langer | 1 |
- Stock Market
- Insiders
- John Senaldi
- Company connections